Azapropazone

Azapropazone
Azapropazone molecule
Clinical data
Trade names Rheumox
AHFS/Drugs.com International Drug Names
ATC code M01AX04 (WHO)
Legal status
Legal status
  • UK: POM (Prescription only)
Pharmacokinetic data
Biological half-life 20 hours
Identifiers
CAS Number 13539-59-8 N
PubChem (CID) 26098
ChemSpider 24310 YesY
UNII K2VOT966ZI YesY
KEGG D02966 YesY
ChEBI CHEBI:38010 YesY
ChEMBL CHEMBL1231131 N
Chemical and physical data
Formula C16H20N4O2
Molar mass 300.36 g/mol
3D model (Jmol) Interactive image
Chirality Racemic mixture
 NYesY (what is this?)  (verify)

Azapropazone is a non-steroidal anti-inflammatory drug. It is manufactured by Goldshield under the tradename Rheumox.[1]

It was available in the UK as a prescription-only drug, with restrictions due to certain contra-indications and side-effects.[2] Azopropazone has now been discontinued in the British National Formulary.

Azapropazone has a half-life of approximately 20 hours in humans and is not extensively metabolized.[3]

References

  1. http://home.intekom.com/pharm/cont_eth/rheumox.html
  2. http://www.patient.co.uk/showdoc/30002267/
  3. Jones CJ (1976). "The pharmacology and pharmacokinetics of azapropazone - a review". Curr Med Res Opin. 4 (1): 3–16. doi:10.1185/03007997609109361. PMID 770078.



This article is issued from Wikipedia - version of the 4/19/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.